MF Researcher Database

研究者データベース

詳細
松井　博
マツイ　ヒロシ
重粒子線医学センター
講師
Last Updated :2024/03/29

研究者基本情報

研究者

  • 氏名

    松井　博, マツイ　ヒロシ

所属

  • 重粒子線医学センター, 講師

基本情報

  • 研究者氏名（日本語）

    松井, 博

  • 研究者氏名（カナ）

    マツイ, ヒロシ

使用外国語

  • 発表に使用する外国語

    英語

  • 執筆に使用する外国語

    英語

所属

  • 群馬大学, 講師
  • 群馬大学, 講師

所属部局等

  • 所属情報

    重粒子線医学推進機構, 重粒子線医学センター

  • 職名情報

    講師

学歴

  • 2004年
  • 1995年, 高知医科大学
  • 2004年, 群馬大学大学院, 器官代謝制御学講座泌尿器病態学
  • 1995年, 高知医科大学, 医学部

学位

  • 医学博士
  • 条件付必須項目の入力がありません

経歴

  • 群馬大学, 講師, 准教授・常勤専任講師相当

研究活動情報

研究分野

  • ライフサイエンス, 泌尿器科学

研究キーワード

  • 前立腺癌
  • 責任遺伝子
  • 遺伝子多型
  • 家族性前立腺癌

論文

  • Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3, SUZUKI KAZUHIRO / ITO KAZUTO / YAMAMOTO TAKUMI / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / KOIKE HIDEKAZU / MATSUI HIROSHI / ONO YOSHIHIRO / HASUMI MASARU / NAKAZATO HARUKI / OKUGI HIRONOBU / SEKINE YOSHITAKA / OOKI KAZUNARI, 2002年06月, Int J Cancer
  • Gene expression profiles in human BPH: utilization of laser-capture microdissection and quantitative real-time PCR, SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI / MATSUI HIROSHI / HASUMI MASARU / ONO YOSHIHIRO / NAKAZATO HARUKI / KOIKE HIDEKAZU / ITO KAZUTO / FUKABORI YOSHITATSU / KUROKAWA KOHEI, 2001年11月, Anticancer Res
  • Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia, MATSUMOTO KAZUHISA / SUZUKI KAZUHIRO / KOIKE HIDEKAZU / HASUMI MASARU / MATSUI HIROSHI / OKUGI HIRONOBU / SHIBATA YASUHIRO / ITO KAZUTO / YAMANAKA HIDETOSHI, 2003年09月, Anticancer Res
  • Association of genetic polymorphisms of Glutathione-S-transpherase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population, NAKAZATO HARUKI / ITO KAZUTO / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / SUZUKI KAZUHIRO / MATSUI HIROSHI / KOIKE HIDEKAZU / OKUGI HIRONOBU / OHTAKE NOBUAKI / TAKEI TOMOYUKI / NAKATA SEIJI / HASUMI MASARU, 2003年05月, Anticancer Res
  • A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese, SUZUKI KAZUHIRO / ITO KAZUTO / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / MATSUI HIROSHI / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI / NAKAZATO HARUKI / OKUGI HIRONOBU / KOIKE HIDEKAZU / ONO YOSHIHIRO, 2003年07月, J Biomed Sci
  • Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate cancer risk in a Japanese population, SUZUKI KAZUHIRO / ITO KAZUTO / YAMANAKA HIDETOSHI / NAKAZATO HARUKI / MATSUI HIROSHI / KOIKE HIDEKAZU / OKUGI HIRONOBU / KASHIWAGI BUNZOU / NISHII MASAHIRO / OHTAKE NIBUAKI / NAKATA SEIJI, 2003年10月, Cancer
  • Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues, HASUMI MASARU / SUZUKI KAZUHIRO / MATSUI HIROSHI / KOIKE HIDEKAZU / ITO KAZUTO / YAMANAKA HIDETOSHI, 2003年10月, Cancer Lett
  • Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study, SUZUKI KAZUHIRO / HATORI MOTOAKI / ITO KAZUTO / YAMANAKA HIDETOSHI / MATSUI HIROSHI / NAKAZATO HARUKI / KOIKE HIDEKAZU / OKUGI HIRONOBU / HASUMI MASARU / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI, 2003年06月, Cancer Lett
  • Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population, SUZUKI KAZUHIRO / ITO KAZUTO / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI / MATSUI HIROSHI / ONO YOSHIHIRO / NAKAZATO HARUKI / HASUMI MASARU / KOIKE HIDEKAZU, 2002年11月, Anticancer Res
  • Methylation status of insulin-like growth factor-binding protein-3 promoter in prostate cancer tissues., Hironobu Okugi, Hidekazu Koike, Yoshitaka Sekine, Hiroshi Matsui, Kauzhiro Suzuki, 2006年, Asia-Pacific Journal of Clinical Oncology
  • Novel amino acid substitutional mutation, tyrosine-739-aspartic acid, in the androgen receptor gene in complete androgen insensitivity syndrome, SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / NAKAZATO HARUKI / HASUMI MASARU / MATSUI HIROSHI / ITO KAZUTO / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, 2001年06月, Int J Androl
  • Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population., Koike H, Nakazato H, Ohtake N, Matsui H, Okugi H, Shibata Y, Nakata S, Yamanaka H, Suzuki K., 2008年03月, Int Urol Nephrol.
  • Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor., Sekine Y, Furuya Y, Nishii M, Koike H, Matsui H, Suzuki K., 2008年07月, Biochem Biophys Res Commun.
  • Association of 2 Common Chromosome 8q24 Variants, SNP rs1447295 and Microsatellite Marker DG8S737, With Familial Prostate Cancer and High Grade Disease in a Japanese Population. , Tatsuya Hamano,* Hiroshi Matsui,*,(* Equal study contribution.) Yoshitaka Sekine, Nobuaki Ohtake, Seiji Nakata and Kazuhiro Suzuki, 2010年08月, J Urol.
  • Genomewide linkage analysis of familial prostate cancer in the Japanese population., Matsui H, Suzuki K, Ohtake N, Nakata S, Takeuchi T, Yamanaka H, Inoue I. , 2004年01月, J Hum Genet.
  • Polymorphisms of DNA repair genes, XRCC1 and XRCC3, and susceptibility to familial prostate cancer in a Japanese population. , Hamano T, Matsui H, Ohtake N, Nakata S and Suzuki K. , 2008年01月, Asia-Pacific Journal of Clinical Oncology 4(1):21-26, 2008.
  • Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer. , Okamura K, Koike H, Sekine Y, Matsui H and Suzuki K. , 2009年08月, Cancer Epidemiology
  • Survivin is associated with cell proliferation and has a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer., Koike H, Morikawa Y, Sekine Y, Matsui H, Shibata Y, Suzuki K., 2011年04月, J Urol.
  • Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation., Morikawa Y, Koike H, Sekine Y, Matsui H, Shibata Y, Ito K, Suzuki K., 2012年05月, Biochem Biophys Res Commun.
  • Luteinizing hormone (LH)-releasing hormone agonist reduces serum adrenal androgen levels in prostate cancer patients: implications for the effect of LH on the adrenal glands., Nishii M, Nomura M, Sekine Y, Koike H, Matsui H, Shibata Y, Ito K, Oyama T, Suzuki K., 2012年11月, J Androl.
  • Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer., Fukuma Y, Matsui H, Koike H, Sekine Y, Shechter I, Ohtake N, Nakata S, Ito K, Suzuki K., 2012年12月, Prostate Cancer Prostatic Dis.
  • Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range, Ito, Kazuto; Miyakubo, Mai; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Suzuki, Kazuhiro, 2013年, WORLD JOURNAL OF UROLOGY
    DOI
  • 前立腺がんの重粒子線治療はどこまでエビデンスがあるのか?, 松井 博,加藤 弘之,神沼 拓也,伊藤 一人,鈴木 和浩,大野 達也, 2013年11月, 腫瘍内科, 12, 5, 515-521
  • YM155 reverses rapamycin resistance in renal cancer by decreasing survivin, Koike, Hidekazu; Nitta, Takashi; Sekine, Yoshitaka; Arai, Seiji; Furuya, Yosuke; Nomura, Masashi; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Oyama, Tetsunari; Suzuki, Kazuhiro, 2014年10月, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    DOI
  • Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life, Ishikawa, Hitoshi; Katoh, Hiroyuki; Kaminuma, Takuya; Kawamura, Hidemasa; Ito, Kazuto; Matsui, Hiroshi; Hirato, Junko; Shimizu, Nobuaki; Takezawa, Yutaka; Tsuji, Hiroshi; Suzuki, Kazuhiro; Ohno, Tatsuya; Nakano, Takashi, 2015年10月, ANTICANCER RESEARCH
  • A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer, Suzuki, Kazuhiro; Ozono, Seiichiro; Yamaguchi, Akito; Koike, Hidekazu; Matsui, Hiroshi; Nagata, Masao; Takubo, Takatoshi; Miyashita, Kana; Matsushima, Takafumi; Akaza, Hideyuki, 2015年, CANCER CHEMOTHERAPY AND PHARMACOLOGY
    DOI
  • Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer, Kato, Haruo; Furuya, Yosuke; Miyazawa, Yoshiyuki; Miyao, Takeshi; Syuto, Takahiro; Nomura, Masashi; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2016年11月, ANTICANCER RESEARCH
    DOI
  • Germline Variants of Prostate Cancer in Japanese Families, Hayano, Takahide; Matsui, Hiroshi; Nakaoka, Hirofumi; Ohtake, Nobuaki; Hosomichi, Kazuyoshi; Suzuki, Kazuhiro; Inoue, Ituro, 2016年10月, PLOS ONE
    DOI
  • A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2017年, BMC UROLOGY
    DOI
  • Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL, Fujizuka, Yuji; Ito, Kazuto; Oki, Ryo; Suzuki, Rie; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Suzuki, Kazuhiro, 2017年, INTERNATIONAL JOURNAL OF UROLOGY
    DOI
  • Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2017年, ANTICANCER RESEARCH
    DOI
  • Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content, Shibata, Yasuhiro; Arai, Seiji; Miyazawa, Yoshiyuki; Shuto, Takahiro; Nomura, Masashi; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Ito, Kazuto; Suzuki, Kazuhiro, 2017年, PROSTATE
    DOI
  • Suicide attempt with an overdose of sunitinib, Arai, Seiji; Matsui, Hiroshi; Ohki, Ryo; Miyazawa, Yoshiyuki; Koike, Hidekazu; Hashita, Tadahiro; Katsuyama, Yoshihiko; Sekine, Yoshitaka; Nomura, Masashi; Shibata, Yasuhiro; Hatori, Motoaki; Ito, Kazuto; Yamamoto, Koujirou; Ohmori, Shigeru; Suzuki, Kazuhiro, 2014年10月, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    DOI
  • Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanism, Sekine, Yoshitaka; Nakayama, Hiroshi; Miyazawa, Yoshiyuki; Kato, Haruo; Furuya, Yosuke; Arai, Seiji; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2018年, ONCOLOGY LETTERS
    DOI
  • Effect of Androgen-deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2018年, IN VIVO
    DOI
  • 家族性前立腺癌の遺伝子解析と臨床応用の可能性, 松井 博,大竹 伸明,中田 誠司,栗原 聰太,小池 秀和,鈴木 和浩 , 2016年, Prostate journal, 3, 1, 53-60
  • Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population, Okugi, Hironobu;Nakazato, Haruki;Matsui, Hiroshi;Ohtake, Nobuaki;Nakata, Seiji;Suzuki, Kazuhiro, 2006年, CANCER DETECTION AND PREVENTION, CANCER DETECTION AND PREVENTION, 30, 3, 262, 268
    DOI
  • Polymorphisms of DNA repair genes, XRCC1 and XRCC3, and susceptibility to familial prostate cancer in a Japanese population, Hamano, Tatsuya;Matsui, Hiroshi;Ohtake, Nobuaki;Nakata, Seiji;Suzuki, Kazuhiro, 2008年, ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 4, 1, 21, 26
    DOI
  • Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor, Sekine, Yoshitaka;Furuya, Yosuke;Nishii, Masahiro;Koike, Hidekazu;Matsui, Hiroshi;Suzuki, Kazuhiro, 2008年, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 372, 2, 356, 361
    DOI
  • Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer, Okamura, Keigo;Koike, Hidekazu;Sekine, Yoshitaka;Matsui, Hiroshi;Suzuki, Kazuhiro, 2009年, CANCER EPIDEMIOLOGY, CANCER EPIDEMIOLOGY, 33, 2, 137, 141
    DOI
  • Association of SNP rs1447295 and Microsatellite Marker DG8S737 With Familial Prostate Cancer and High Grade Disease, Hamano, Tatsuya;Matsui, Hiroshi;Sekine, Yoshitaka;Ohtake, Nobuaki;Nakata, Seiji;Suzuki, Kazuhiro, 2010年, JOURNAL OF UROLOGY, JOURNAL OF UROLOGY, 184, 2, 738, 742
    DOI
  • Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation, Morikawa, Yasuyuki;Koike, Hidekazu;Sekine, Yoshitaka;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2012年, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 419, 3, 584, 589
    DOI
  • Luteinizing Hormone (LH)-Releasing Hormone Agonist Reduces Serum Adrenal Androgen Levels in Prostate Cancer Patients: Implications for the Effect of LH on the Adrenal Glands, Nishii, Masahiro;Nomura, Masashi;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Oyama, Tetsunari;Suzuki, Kazuhiro, 2012年, JOURNAL OF ANDROLOGY, JOURNAL OF ANDROLOGY, 33, 6, 1233, 1238
    DOI
  • Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range, Ito, Kazuto;Miyakubo, Mai;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2013年, WORLD JOURNAL OF UROLOGY, WORLD JOURNAL OF UROLOGY, 31, 2, 305, 311
    DOI
  • A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients, Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Syuto, Takahiro;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2017年, BMC UROLOGY, BMC UROLOGY, 17
    DOI
  • Effect of Androgen-deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer, Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Syuto, Takahiro;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2018年, IN VIVO, IN VIVO, 32, 2, 409, 412
    DOI
  • Assessment of antimicrobiral prophylaxis in transperineal prostate biopsy: A single-center retrospective study of 485 cases, Baba, Kyoko;Sekine, Yoshitaka;Miyazawa, Yoshiyuki;Syuto, Takahiro;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2018年, JOURNAL OF INFECTION AND CHEMOTHERAPY, JOURNAL OF INFECTION AND CHEMOTHERAPY, 24, 8, 637, 640
    DOI
  • Long-term longitudinal changes in baseline PSA distribution and estimated prevalence of prostate cancer in male Japanese participants of population-based PSA screening, Oki, Ryo;Ito, Kazuto;Suzuki, Rie;Fujizuka, Yuji;Arai, Seiji;Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2018年, INTERNATIONAL JOURNAL OF CANCER, INTERNATIONAL JOURNAL OF CANCER, 143, 7, 1611, 1619
    DOI
  • Clinical Outcomes and Survival Surrogacy Studies of PSA Declines and PSA kinetics Following Enzalutamide in Men with mCRPC, Miyazawa, Yoshiyuki;Miyao, Takeshi;Nakayama, Hiroshi;Kurihara, Sota;Oki, Ryo;Syuto, Takahiro;Sekine, Yoshitaka;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Ito, Kazuto;Suzuki, Kazuhiro, 2018年, INTERNATIONAL JOURNAL OF UROLOGY, INTERNATIONAL JOURNAL OF UROLOGY, 25, 357, 357
  • Hypofractionated Intensity-modulated Radiotherapy for Intermediate- and High-risk Prostate Cancer: A Retrospective Study, Kubo, Nobuteru;Kawamura, Hidemasa;Oike, Takahiro;Sato, Hiro;Iwanaga, Mototaro;Mizukami, Tatsuji;Adachi, Akiko;Matsui, Hiroshi;Ito, Kazuto;Suzuki, Kazuhiro;Nakano, Takashi, 2019年, IN VIVO, IN VIVO, 33, 4, 1235, 1241
    DOI
  • An exploratory retrospective multicenter study of prognostic factors in mCRPC patients undergoing enzalutamide treatment: Focus on early PSA decline and kinetics at time of progression, Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Shimizu, Nobuaki;Takezawa, Yutaka;Nakamura, Toshiyuki;Miyao, Takeshi;Nakayama, Hiroshi;Kurihara, Sota;Syuto, Takahiro;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2019年, PROSTATE, PROSTATE, 79, 12, 1462, 1470
    DOI
  • Quality of life in prostate cancer patients receiving particle radiotherapy: A review of the literature, Kawamura, Hidemasa;Kubo, Nobuteru;Sato, Hiro;Miyasaka, Yuhei;Matsui, Hiroshi;Ito, Kazuto;Suzuki, Kazuhiro;Ohno, Tatsuya, 2020年, INTERNATIONAL JOURNAL OF UROLOGY, INTERNATIONAL JOURNAL OF UROLOGY, 27, 1, 24, 29
    DOI
  • Exploratory study of prognostic factors in mCRPC patients who administered enzalutamide focusing on early PSA decline and PSA kinetics at PSA progression: Results of retrospective multicenter study., Miyazawa, Yoshiyuki;Shimizu, Nobuaki;Takezawa, Yutaka;Nakamura, Toshiyuki;Miyao, Takeshi;Nakayama, Hiroshi;Kurihara, Sota;Syuto, Takahiro;Nomura, Masashi;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2019年, JOURNAL OF CLINICAL ONCOLOGY, JOURNAL OF CLINICAL ONCOLOGY, 37, 7
  • Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study "GUNMA0702", Kawamura, Hidemasa;Kubo, Nobuteru;Sato, Hiro;Mizukami, Tatsuji;Katoh, Hiroyuki;Ishikawa, Hitoshi;Ohno, Tatsuya;Matsui, Hiroshi;Ito, Kazuto;Suzuki, Kazuhiro;Nakano, Takashi;Gunma Univ Heavy Ion Med Ctr, 2020年, BMC CANCER, BMC CANCER, 20, 1
    DOI
  • A prospective study of the relationship between clinical outcomes of enzalutamide and serum androgen levels measured by LC-MS/MS in patients with CRPC, Miyazawa, Yoshiyuki;Miyao, Takeshi;Nakamura, Toshiyuki;Takezawa, Yutaka;Shimizu, Nobuaki;Matsuo, Yasushige;Ogura, Haruyuki;Takei, Tomoyuki;Oka, Daisuke;Arai, Seiji;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2020年, JOURNAL OF CLINICAL ONCOLOGY, JOURNAL OF CLINICAL ONCOLOGY, 38, 6
  • Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer, Darwis, Narisa Dewi Maulany;Oike, Takahiro;Kawamura, Hidemasa;Kawahara, Masahiro;Kubo, Nobuteru;Sato, Hiro;Miyasaka, Yuhei;Katoh, Hiroyuki;Ishikawa, Hitoshi;Matsui, Hiroshi;Miyazawa, Yoshiyuki;Ito, Kazuto;Suzuki, Kazuhiro;Gondhowiardjo, Soehartati;Nakano, Takashi;Ohno, Tatsuya, 2020年, CANCERS, CANCERS, 12, 3
    DOI

MISC

  • Polymorphisms of DNA repair genes, XRCC1 and XRCC3, and susceptibility to familial prostate cancer in a Japanese population, Tatsuya Hamano; Hiroshi Matsui; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, 2008年03月, ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 4, 1, 21, 26
    DOI
  • Polymorphisms of DNA repair genes, XRCC1 and XRCC3, and susceptibility to familial prostate cancer in a Japanese population, Tatsuya Hamano; Hiroshi Matsui; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, 2008年03月, ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 4, 1, 21, 26
    DOI
  • Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor, Yoshitaka Sekine; Yosuke Furuya; Masahiro Nishii; Hidekazu Koike; Hiroshi Matsui; Kazuhiro Suzuki, 2008年07月, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 372, 2, 356, 361
    DOI
  • Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor, Yoshitaka Sekine; Yosuke Furuya; Masahiro Nishii; Hidekazu Koike; Hiroshi Matsui; Kazuhiro Suzuki, 2008年07月, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 372, 2, 356, 361
    DOI
  • Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population, Hidekazu Koike; Haruki Nakazato; Nobuaki Ohtake; Hiroshi Matsui; Hironobu Okugi; Yasuhiro Shibata; Seiji Nakata; Hidetoshi Yamanaka; Kazuhiro Suzuki, 2008年12月, INTERNATIONAL UROLOGY AND NEPHROLOGY, 40, 4, 947, 951
    DOI
  • Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population, Hidekazu Koike; Haruki Nakazato; Nobuaki Ohtake; Hiroshi Matsui; Hironobu Okugi; Yasuhiro Shibata; Seiji Nakata; Hidetoshi Yamanaka; Kazuhiro Suzuki, 2008年12月, INTERNATIONAL UROLOGY AND NEPHROLOGY, 40, 4, 947, 951
    DOI
  • A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer, Kazuhiro Suzuki; Seiichiro Ozono; Akito Yamaguchi; Hidekazu Koike; Hiroshi Matsui; Masao Nagata; Takatoshi Takubo; Kana Miyashita; Takafumi Matsushima; Hideyuki Akaza, 2015年02月, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 75, 2, 373, 380
    DOI
  • A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer, Kazuhiro Suzuki; Seiichiro Ozono; Akito Yamaguchi; Hidekazu Koike; Hiroshi Matsui; Masao Nagata; Takatoshi Takubo; Kana Miyashita; Takafumi Matsushima; Hideyuki Akaza, 2015年02月, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 75, 2, 373, 380
    DOI
  • Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life, Hitoshi Ishikawa; Hiroyuki Katoh; Takuya Kaminuma; Hidemasa Kawamura; Kazuto Ito; Hiroshi Matsui; Junko Hirato; Nobuaki Shimizu; Yutaka Takezawa; Hiroshi Tsuji; Kazuhiro Suzuki; Tatsuya Ohno; Takashi Nakano, 2015年10月, ANTICANCER RESEARCH, 35, 10, 5559, 5566
  • Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life, Hitoshi Ishikawa; Hiroyuki Katoh; Takuya Kaminuma; Hidemasa Kawamura; Kazuto Ito; Hiroshi Matsui; Junko Hirato; Nobuaki Shimizu; Yutaka Takezawa; Hiroshi Tsuji; Kazuhiro Suzuki; Tatsuya Ohno; Takashi Nakano, 2015年10月, ANTICANCER RESEARCH, 35, 10, 5559, 5566
  • Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer, Keigo Okamura; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Kazuhiro Suzuki, 2009年08月, CANCER EPIDEMIOLOGY, 33, 2, 137, 141
    DOI
  • Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer, Keigo Okamura; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Kazuhiro Suzuki, 2009年08月, CANCER EPIDEMIOLOGY, 33, 2, 137, 141
    DOI
  • Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range, Kazuto Ito; Mai Miyakubo; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 2013年04月, WORLD JOURNAL OF UROLOGY, 31, 2, 305, 311
    DOI
  • Luteinizing Hormone (LH)-Releasing Hormone Agonist Reduces Serum Adrenal Androgen Levels in Prostate Cancer Patients: Implications for the Effect of LH on the Adrenal Glands, Masahiro Nishii; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Tetsunari Oyama; Kazuhiro Suzuki, 2012年11月, JOURNAL OF ANDROLOGY, 33, 6, 1233, 1238
    DOI
  • Luteinizing Hormone (LH)-Releasing Hormone Agonist Reduces Serum Adrenal Androgen Levels in Prostate Cancer Patients: Implications for the Effect of LH on the Adrenal Glands, Masahiro Nishii; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Tetsunari Oyama; Kazuhiro Suzuki, 2012年11月, JOURNAL OF ANDROLOGY, 33, 6, 1233, 1238
    DOI
  • Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer, Y. Fukuma; H. Matsui; H. Koike; Y. Sekine; I. Shechter; N. Ohtake; S. Nakata; K. Ito; K. Suzuki, 2012年12月, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 4, 339, 345
    DOI
  • Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer, Y. Fukuma; H. Matsui; H. Koike; Y. Sekine; I. Shechter; N. Ohtake; S. Nakata; K. Ito; K. Suzuki, 2012年12月, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 4, 339, 345
    DOI
  • Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation, Yasuyuki Morikawa; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2012年03月, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 419, 3, 584, 589
    DOI
  • Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation, Yasuyuki Morikawa; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2012年03月, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 419, 3, 584, 589
    DOI
  • Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3, K Suzuki; H Koike; H Matsui; Y Ono; M Hasumi; H Nakazato; H Okugi; Y Sekine; K Oki; K Ito; T Yamamoto; Y Fukabori; K Kurokawa; H Yamanaka, 2002年06月, INTERNATIONAL JOURNAL OF CANCER, 99, 6, 846, 852
    DOI
  • Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3, K Suzuki; H Koike; H Matsui; Y Ono; M Hasumi; H Nakazato; H Okugi; Y Sekine; K Oki; K Ito; T Yamamoto; Y Fukabori; K Kurokawa; H Yamanaka, 2002年06月, INTERNATIONAL JOURNAL OF CANCER, 99, 6, 846, 852
    DOI
  • Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues, M Hasumi; K Suzuki; H Matsui; H Koike; K Ito; H Yamanaka, 2003年10月, CANCER LETTERS, 200, 2, 187, 195
    DOI
  • Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues, M Hasumi; K Suzuki; H Matsui; H Koike; K Ito; H Yamanaka, 2003年10月, CANCER LETTERS, 200, 2, 187, 195
    DOI
  • Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study, K Suzuki; H Matsui; H Nakazato; H Koike; H Okugi; M Hasumi; N Ohtake; S Nakata; T Takei; M Hatori; K Ito; H Yamanaka, 2003年06月, CANCER LETTERS, 195, 2, 177, 183
    DOI
  • Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study, K Suzuki; H Matsui; H Nakazato; H Koike; H Okugi; M Hasumi; N Ohtake; S Nakata; T Takei; M Hatori; K Ito; H Yamanaka, 2003年06月, CANCER LETTERS, 195, 2, 177, 183
    DOI
  • A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese, K Suzuki; H Matsui; N Ohtake; S Nakata; T Takei; H Nakazato; H Okugi; H Koike; Y Ono; K Ito; K Kurokawa; H Yamanaka, 2003年07月, JOURNAL OF BIOMEDICAL SCIENCE, 10, 4, 430, 435
    DOI
  • A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese, K Suzuki; H Matsui; N Ohtake; S Nakata; T Takei; H Nakazato; H Okugi; H Koike; Y Ono; K Ito; K Kurokawa; H Yamanaka, 2003年07月, JOURNAL OF BIOMEDICAL SCIENCE, 10, 4, 430, 435
    DOI
  • Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population, K Suzuki; H Nakazato; H Matsui; H Koike; H Okugi; B Kashiwagi; M Nishii; N Ohtake; S Nakata; K Ito; H Yamanaka, 2003年10月, CANCER, 98, 7, 1411, 1416
    DOI
  • Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population, K Suzuki; H Nakazato; H Matsui; H Koike; H Okugi; B Kashiwagi; M Nishii; N Ohtake; S Nakata; K Ito; H Yamanaka, 2003年10月, CANCER, 98, 7, 1411, 1416
    DOI
  • Genomewide linkage analysis of familial prostate cancer in the Japanese population, H Matsui; K Suzuki; N Ohtake; S Nakata; T Takeuchi; H Yamanaka; Inoue, I, 2004年01月, JOURNAL OF HUMAN GENETICS, 49, 1, 9, 15
    DOI
  • Genomewide linkage analysis of familial prostate cancer in the Japanese population, H Matsui; K Suzuki; N Ohtake; S Nakata; T Takeuchi; H Yamanaka; Inoue, I, 2004年01月, JOURNAL OF HUMAN GENETICS, 49, 1, 9, 15
    DOI
  • Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer, Haruo Kato; Yosuke Furuya; Yoshiyuki Miyazawa; Takeshi Miyao; Takahiro Syuto; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2016年11月, ANTICANCER RESEARCH, 36, 11, 6141, 6149
    DOI
  • Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer, Haruo Kato; Yosuke Furuya; Yoshiyuki Miyazawa; Takeshi Miyao; Takahiro Syuto; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2016年11月, ANTICANCER RESEARCH, 36, 11, 6141, 6149
    DOI
  • Survivin Is Associated With Cell Proliferation and Has a Role in 1a,25-Dihydroxyvitamin D-3 Induced Cell Growth Inhibition in Prostate Cancer, Hidekazu Koike; Yasuyuki Morikawa; Yoshitaka Sekine; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 2011年04月, JOURNAL OF UROLOGY, 185, 4, 1497, 1503
    DOI
  • Survivin Is Associated With Cell Proliferation and Has a Role in 1a,25-Dihydroxyvitamin D-3 Induced Cell Growth Inhibition in Prostate Cancer, Hidekazu Koike; Yasuyuki Morikawa; Yoshitaka Sekine; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 2011年04月, JOURNAL OF UROLOGY, 185, 4, 1497, 1503
    DOI
  • YM155 reverses rapamycin resistance in renal cancer by decreasing survivin, Hidekazu Koike; Takashi Nitta; Yoshitaka Sekine; Seiji Arai; Yosuke Furuya; Masashi Nomura; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Tetsunari Oyama; Kazuhiro Suzuki, 2014年10月, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 140, 10, 1705, 1713
    DOI
  • YM155 reverses rapamycin resistance in renal cancer by decreasing survivin, Hidekazu Koike; Takashi Nitta; Yoshitaka Sekine; Seiji Arai; Yosuke Furuya; Masashi Nomura; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Tetsunari Oyama; Kazuhiro Suzuki, 2014年10月, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 140, 10, 1705, 1713
    DOI
  • Suicide attempt with an overdose of sunitinib, Seiji Arai; Hiroshi Matsui; Ryo Ohki; Yoshiyuki Miyazawa; Hidekazu Koike; Tadahiro Hashita; Yoshihiko Katsuyama; Yoshitaka Sekine; Masashi Nomura; Yasuhiro Shibata; Motoaki Hatori; Kazuto Ito; Koujirou Yamamoto; Shigeru Ohmori; Kazuhiro Suzuki, 2014年10月, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 78, 4, 933, 935, 速報，短報，研究ノート等（学術雑誌）
    DOI
  • Suicide attempt with an overdose of sunitinib, Seiji Arai; Hiroshi Matsui; Ryo Ohki; Yoshiyuki Miyazawa; Hidekazu Koike; Tadahiro Hashita; Yoshihiko Katsuyama; Yoshitaka Sekine; Masashi Nomura; Yasuhiro Shibata; Motoaki Hatori; Kazuto Ito; Koujirou Yamamoto; Shigeru Ohmori; Kazuhiro Suzuki, 2014年10月, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 78, 4, 933, 935, 速報，短報，研究ノート等（学術雑誌）
    DOI
  • Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content, Yasuhiro Shibata; Seiji Arai; Yoshiyuki Miyazawa; Takahiro Shuto; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Kazuto Ito; Kazuhiro Suzuki, 2017年05月, PROSTATE, 77, 6, 672, 680
    DOI
  • Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content, Yasuhiro Shibata; Seiji Arai; Yoshiyuki Miyazawa; Takahiro Shuto; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Kazuto Ito; Kazuhiro Suzuki, 2017年05月, PROSTATE, 77, 6, 672, 680
    DOI
  • A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients, Yoshiyuki Miyazawa; Yoshitaka Sekine; Takahiro Syuto; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2017年08月, BMC UROLOGY, 17, 70
    DOI
  • Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL, Yuji Fujizuka; Kazuto Ito; Ryo Oki; Rie Suzuki; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 2017年08月, INTERNATIONAL JOURNAL OF UROLOGY, 24, 8, 602, 609
    DOI
  • Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL, Yuji Fujizuka; Kazuto Ito; Ryo Oki; Rie Suzuki; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 2017年08月, INTERNATIONAL JOURNAL OF UROLOGY, 24, 8, 602, 609
    DOI
  • Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Yoshiyuki Miyazawa; Yoshitaka Sekine; Takahiro Syuto; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2017年07月, ANTICANCER RESEARCH, 37, 7, 3667, 3671
    DOI
  • Germline Variants of Prostate Cancer in Japanese Families., Takahide Hayano; Hiroshi Matsui; Hirofumi Nakaoka; Nobuaki Ohtake; Kazuyoshi Hosomichi; Kazuhiro Suzuki; Ituro Inoue, 2016年, PloS one, 11, 10, e0164233
    DOI
  • Germline Variants of Prostate Cancer in Japanese Families., Takahide Hayano; Hiroshi Matsui; Hirofumi Nakaoka; Nobuaki Ohtake; Kazuyoshi Hosomichi; Kazuhiro Suzuki; Ituro Inoue, 2016年, PloS one, 11, 10, e0164233
    DOI
  • Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia, MATSUMOTO KAZUHISA; SUZUKI KAZUHIRO; KOIKE HIDEKAZU; HASUMI MASARU; MATSUI HIROSHI; OKUGI HIRONOBU; SHIBATA YASUHIRO; ITO KAZUTO; YAMANAKA HIDETOSHI, 2003年, Anticancer Res, 23(5A):3767-3773
  • Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population, SUZUKI KAZUHIRO; ITO KAZUTO; OHTAKE NOBUAKI; NAKATA SEIJI; TAKEI TOMOYUKI; MATSUI HIROSHI; ONO YOSHIHIRO; NAKAZATO HARUKI; HASUMI MASARU; KOIKE HIDEKAZU, 2002年, Anticancer Res, 22(6B):3507-3511
  • Association of genetic polymorphisms of Glutathione-S-transpherase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population, NAKAZATO HARUKI; ITO KAZUTO; KUROKAWA KOHEI; YAMANAKA HIDETOSHI; SUZUKI KAZUHIRO; MATSUI HIROSHI; KOIKE HIDEKAZU; OKUGI HIRONOBU; OHTAKE NOBUAKI; TAKEI TOMOYUKI; NAKATA SEIJI; HASUMI MASARU, 2003年, Anticancer Res, 23(3C):2897-2902
  • Gene expression profiles in human BPH: utilization of laser-capture microdissection and quantitative real-time PCR, SUZUKI KAZUHIRO; YAMANAKA HIDETOSHI; MATSUI HIROSHI; HASUMI MASARU; ONO YOSHIHIRO; NAKAZATO HARUKI; KOIKE HIDEKAZU; ITO KAZUTO; FUKABORI YOSHITATSU; KUROKAWA KOHEI, 2001年, Anticancer Res, 21(6A): 3861-3864
  • Novel amino acid substitutional mutation, tyrosine-739-aspartic acid, in the androgen receptor gene in complete androgen insensitivity syndrome, SUZUKI KAZUHIRO; FUKABORI YOSHITATSU; NAKAZATO HARUKI; HASUMI MASARU; MATSUI HIROSHI; ITO KAZUTO; KUROKAWA KOHEI; YAMANAKA HIDETOSHI, 2001年, Int J Androl, 24(3):183-8
    DOI
  • Association of 2 Common Chromosome 8q24 Variants, SNP rs1447295 and Microsatellite Marker DG8S737, With Familial Prostate Cancer and High Grade Disease in a Japanese Population., Tatsuya Hamano; Hiroshi Matsui; Equal study contribution; Yoshitaka Sekine; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, 2010年, J Urol., 184, 2, 738, 42
    DOI
  • Methylation status of insulin-like growth factor-binding protein-3 promoter in prostate cancer tissues, Hironobu Okugi; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Kazuhiro Suzuki, 2006年09月, Asia-Pacific Journal of Clinical Oncology, 2, 3, 144, 149
    DOI
  • Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanism, Yoshitaka Sekine; Hiroshi Nakayama; Yoshiyuki Miyazawa; Haruo Kato; Yosuke Furuya; Seiji Arai; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2018年03月01日, Oncology Letters, 15, 3, 3167, 3172
    DOI
  • Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range, Ito, Kazuto; Miyakubo, Mai; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Suzuki, Kazuhiro, 2013年, WORLD JOURNAL OF UROLOGY, 31, 2, 305, 311
    DOI
  • Effect of Androgen-deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2018年, IN VIVO, 32, 2, 409, 412
    DOI
  • Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia, MATSUMOTO KAZUHISA; SUZUKI KAZUHIRO; KOIKE HIDEKAZU; HASUMI MASARU; MATSUI HIROSHI; OKUGI HIRONOBU; SHIBATA YASUHIRO; ITO KAZUTO; YAMANAKA HIDETOSHI, 2003年, Anticancer Res, 23(5A):3767-3773
  • Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population, SUZUKI KAZUHIRO; ITO KAZUTO; OHTAKE NOBUAKI; NAKATA SEIJI; TAKEI TOMOYUKI; MATSUI HIROSHI; ONO YOSHIHIRO; NAKAZATO HARUKI; HASUMI MASARU; KOIKE HIDEKAZU, 2002年, Anticancer Res, 22(6B):3507-3511
  • Association of genetic polymorphisms of Glutathione-S-transpherase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population, NAKAZATO HARUKI; ITO KAZUTO; KUROKAWA KOHEI; YAMANAKA HIDETOSHI; SUZUKI KAZUHIRO; MATSUI HIROSHI; KOIKE HIDEKAZU; OKUGI HIRONOBU; OHTAKE NOBUAKI; TAKEI TOMOYUKI; NAKATA SEIJI; HASUMI MASARU, 2003年, Anticancer Res, 23(3C):2897-2902
  • Gene expression profiles in human BPH: utilization of laser-capture microdissection and quantitative real-time PCR, SUZUKI KAZUHIRO; YAMANAKA HIDETOSHI; MATSUI HIROSHI; HASUMI MASARU; ONO YOSHIHIRO; NAKAZATO HARUKI; KOIKE HIDEKAZU; ITO KAZUTO; FUKABORI YOSHITATSU; KUROKAWA KOHEI, 2001年, Anticancer Res, 21(6A): 3861-3864
  • Novel amino acid substitutional mutation, tyrosine-739-aspartic acid, in the androgen receptor gene in complete androgen insensitivity syndrome, SUZUKI KAZUHIRO; FUKABORI YOSHITATSU; NAKAZATO HARUKI; HASUMI MASARU; MATSUI HIROSHI; ITO KAZUTO; KUROKAWA KOHEI; YAMANAKA HIDETOSHI, 2001年, Int J Androl, 24(3):183-8
    DOI
  • Association of 2 Common Chromosome 8q24 Variants, SNP rs1447295 and Microsatellite Marker DG8S737, With Familial Prostate Cancer and High Grade Disease in a Japanese Population., Tatsuya Hamano; Hiroshi Matsui; Equal study contribution; Yoshitaka Sekine; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, 2010年, J Urol., 184, 2, 738, 42
    DOI
  • Methylation status of insulin-like growth factor-binding protein-3 promoter in prostate cancer tissues, Hironobu Okugi; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Kazuhiro Suzuki, 2006年09月, Asia-Pacific Journal of Clinical Oncology, 2, 3, 144, 149
    DOI
  • 前立腺がんの重粒子線治療はどこまでエビデンスがあるのか?, 松井 博; 加藤 弘之; 神沼 拓也; 伊藤 一人; 鈴木 和浩; 大野 達也, 2013年, 腫瘍内科, 12, 5, 515, 521
  • Evaluation of bone turnover/quality markers and bone mineral density in prostate cancer patients receiving androgen deprivation therapy with or without denosumab, Yoshiyuki Miyazawa; Syuto Takahiro; Sekine Yoshitaka; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2017年07月01日, Anticancer Research, 37, 7, 3667, 3671
    DOI
  • Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanism, Yoshitaka Sekine; Hiroshi Nakayama; Yoshiyuki Miyazawa; Haruo Kato; Yosuke Furuya; Seiji Arai; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2018年03月01日, Oncology Letters, 15, 3, 3167, 3172
    DOI
  • 家族性前立腺癌の遺伝子解析と臨床応用の可能性, 松井 博; 大竹 伸明; 中田 誠司; 栗原 聰太; 小池 秀和; 鈴木 和浩, 2016年, Prostate journal, 3, 1, 53, 60
  • A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients, Yoshiyuki Miyazawa; Yoshitaka Sekine; Takahiro Syuto; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2017年08月29日, BMC Urology, 17, 1, 70
    DOI
  • Effect of Androgen-deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2018年, IN VIVO, 32, 2, 409, 412
    DOI

講演・口頭発表等

  • Novel candidate gene for prostate cancer (PC) susceptibility, farnecyl-diphosphate farnecyltransferase 1 (FDFT1): Associations of FDFT1 gene variants with PC risk, and FDFT1 protein function evaluation in PC cells., American Urological Assoication, 2010年
  • A novel candidate gene of susceptibility to prostate cancer, farnecyl-diphosphate farnecyltransferase 1 (FDFT1) gene: association between the variants of the FDFT1 gene and the prostate cancer risk, and the evaluation of the FDFT1 protein function to ・・・, European Association of Urology, 2010年
  • Genomewide linkage analysis of familial prostate cancer in the Japanese population., American Urological Association, 2004年
  • 家族性前立腺癌責任遺伝子の候補: farnesyl-diphosphate farnesyltransferase 1(FDFT1) 遺伝子多型と機能解析についての検討．, 日本泌尿器科学会総会 2010, 2010年
  • 短期内分泌療法に伴う認知機能およびQOL評価, 日本泌尿器科東部学会総会 2009, 2009年
  • 日本人前立腺癌における疾患関連遺伝子座8q24の検討, 日本泌尿器科学会東部総会 2008, 2008年
  • 日本人の家族性および遺伝性前立腺癌におけるMacrophage Scavenger Receptor 1(MSR1)の遺伝子多型の検討, 前立腺癌ワークショップ 2007, 2007年
  • 本邦の家族性前立腺癌における全ゲノム罹患同胞対連鎖解析, 日本泌尿器科学会総会 2004, 2004年
  • 日本人の家族性前立腺癌における全ゲノム罹患同胞対連鎖解析, 第15回前立腺がんワークショップ, 2004年
  • シロドシンによる排尿障害の治療：Urief Dose-Up and QOL Study, 日本泌尿器科学会総会 2009, 2009年
  • Novel candidate gene for prostate cancer (PC) susceptibility, farnecyl-diphosphate farnecyltransferase 1 (FDFT1): Associations of FDFT1 gene variants with PC risk, and FDFT1 protein function evaluation in PC cells., American Urological Assoication, 2010年
  • A novel candidate gene of susceptibility to prostate cancer, farnecyl-diphosphate farnecyltransferase 1 (FDFT1) gene: association between the variants of the FDFT1 gene and the prostate cancer risk, and the evaluation of the FDFT1 protein function to ・・・, European Association of Urology, 2010年
  • Genomewide linkage analysis of familial prostate cancer in the Japanese population., American Urological Association, 2004年
  • 日本人家族性前立腺癌におけるGWASによって同定された遺伝子多型群の検討, 日本家族性腫瘍学会, 2013年
  • 前立腺癌に対する重粒子線治療後の有害事象評価としての尿流量測定および残尿測定の検討, 第101回日本泌尿器科学会総会, 2013年
  • 前立腺癌に対する重粒子線治療後の有害事象評価としての尿流量測定および残尿測定の検討, 第50回日本癌治療学会学術集会, 2012年
  • 家族性前立腺癌の臨床と基礎, 第21回日本腎泌尿器疾患予防医学研究会総会, 2012年
  • 前立腺癌の遺伝的素因：前立腺癌責任遺伝子の同定, 第20回日本腎泌尿器疾患予防医学研究会総会, 2011年
  • 当院における進行性腎細胞癌に対するSunitinibの使用経験, 2011年

Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.